Related Experiment Video
Updated: Nov 23, 2025

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
Impulse control behavior in GBA-mutated parkinsonian patients
Paolo Amami1, Tiziana De Santis2, Federica Invernizzi3
1IRCCS Humanitas Clinical and Research Center, Department of Neurology, via Alessandro Manzoni 56, 20089 Rozzano, Milano, Italy; Humanitas University, Department of Biomedical Sciences, via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milano, Italy.
Impulse control behaviors (ICB) are significantly more common in Parkinson's disease (PD) patients with GBA gene mutations. Dopamine agonist therapy may increase ICB risk in these individuals.
Area of Science:
- Neuroscience
- Genetics
- Movement Disorders
Background:
- GBA gene mutations are a known risk factor for Parkinson's disease (PD).
- Impulse control behaviors (ICB) are severe non-motor symptoms in PD.
- The link between GBA mutations and ICB in PD is not well-established.
Purpose of the Study:
- To determine the prevalence of ICB in PD patients with GBA gene mutations (GBA-PD).
- To describe the characteristics of ICB in GBA-PD patients.
- To compare ICB occurrence between GBA-PD and non-mutated PD (NM-PD) patients.
Main Methods:
- Screened 46 PD patients (23 GBA-PD, 23 NM-PD) for ICB using the QUIP-RS questionnaire.
- Clinical diagnosis and rating of ICB were performed.
- Demographic and clinical variables were compared between groups.
Main Results:
- ICB was more prevalent in GBA-PD patients (52.2%) than in NM-PD patients (13%).
- GBA-PD patients had higher total QUIP-RS scores, with hypersexuality and compulsive shopping being most common.
- Dopamine agonists were frequently used by GBA-PD patients with ICB.
Conclusions:
- ICB is significantly more frequent in GBA-PD patients compared to NM-PD patients.
- GBA carrier status may interact with dopamine agonist therapy to increase ICB risk in PD.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview

